Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
125.05B | 123.52B | 126.44B | 118.05B | 114.25B | 146.93B | Gross Profit |
34.12B | 33.37B | 31.74B | 31.91B | 32.41B | 64.79B | EBIT |
9.89B | 9.44B | 7.78B | 8.62B | 9.45B | 7.24B | EBITDA |
12.89B | 13.74B | 12.82B | 10.06B | 13.27B | 14.13B | Net Income Common Stockholders |
8.40B | 7.57B | 6.72B | 6.22B | 6.22B | 6.65B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
14.19B | 19.47B | 22.08B | 25.25B | 26.59B | 23.05B | Total Assets |
143.09B | 137.09B | 140.23B | 128.98B | 125.41B | 120.04B | Total Debt |
25.63B | 20.30B | 28.09B | 33.69B | 34.58B | 35.26B | Net Debt |
11.44B | 832.00M | 6.04B | 8.45B | 7.99B | 12.21B | Total Liabilities |
63.89B | 56.82B | 67.54B | 69.08B | 70.27B | 72.36B | Stockholders Equity |
79.20B | 80.27B | 72.69B | 59.90B | 55.14B | 47.68B |
Cash Flow | Free Cash Flow | ||||
0.00 | 5.62B | 2.54B | 2.87B | 4.42B | 405.00M | Operating Cash Flow |
0.00 | 8.50B | 4.62B | 8.17B | 11.31B | 12.16B | Investing Cash Flow |
0.00 | -2.30B | 843.00M | -5.74B | -6.58B | -11.21B | Financing Cash Flow |
0.00 | -8.76B | -4.42B | -2.90B | -1.32B | 3.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥79.66B | 9.79 | 1.21% | -2.31% | 12.63% | ||
68 Neutral | ¥261.77B | 16.62 | 1.94% | 25.63% | -24.35% | ||
68 Neutral | ¥23.43B | 37.24 | 2.06% | 0.93% | 330.14% | ||
66 Neutral | ¥64.34B | 9.22 | 1.02% | -5.54% | 3.00% | ||
65 Neutral | $8.92B | 15.03 | 4.68% | 6.11% | 3.59% | -2.49% | |
64 Neutral | ¥23.96B | 17.96 | 1.94% | 6.08% | -22.00% |